[The sulfamethoxazole-trimethoprim combination 1st survey into its in vitro activity in brazzaville, Congo Results of 780 bacterial strains isolated at the National Laboratory and the General Hospital in a single year].
The combination of SMZ-TMP has recently been introduced in Congo. This year (1978), it is very used by many Physicians. To help the congolese Physicians working without antibiogram frequently, we have tested 780 strains from August 1977 to August 78. The susceptibility of these strains was: for E. coli 90%, Klebsiella 69,20%, Staphylococcus 93% and for all strains studied Gram + and Gram - the percentage was 75,51. As many authors have showed, the strains of Pseudomonas, Streptococcus faecalis and Providencia are resistant. Our results remain similar to the results obtained by some french and african authors from 1970 to 1975.
D004338:Drug Combinations; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000187:drug effects; D007709:Klebsiella / Q000187:drug effects; D008826:Microbial Sensitivity Tests; D011549:Pseudomonas / Q000187:drug effects; D012475:Salmonella / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D013420:Sulfamethoxazole / Q000494:pharmacology*; D014295:Trimethoprim / Q000494:pharmacology*
D004338:Drug Combinations; D014295:Trimethoprim; D013420:Sulfamethoxazole
L'association sulfaméthoxazole-triméthoprime (1) Première enquête sur son activité "in vitro" a Brazzaville (Congo). Résultats sur 780 souches bactériennes isolées au Laboratoire National et à l'Hôpital Général en un an.